VANGUARD GROUP INC - PYXIS ONCOLOGY INC ownership

PYXIS ONCOLOGY INC's ticker is and the CUSIP is 747324101. A total of 40 filers reported holding PYXIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of PYXIS ONCOLOGY INC
ValueSharesWeighting
Q3 2023$2,269,084
-19.2%
1,140,243
+4.0%
0.00%
Q2 2023$2,806,910
-34.1%
1,096,449
+3.2%
0.00%
Q1 2023$4,260,821
+246.4%
1,062,549
+15.8%
0.00%
Q4 2022$1,229,888
-31.9%
917,827
+0.0%
0.00%
Q3 2022$1,807,000
-10.6%
917,384
+8.0%
0.00%
Q2 2022$2,021,000
-4.9%
849,080
+61.3%
0.00%
Q1 2022$2,126,000
-62.7%
526,309
+1.2%
0.00%
Q4 2021$5,707,000520,2980.00%
Other shareholders
PYXIS ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Yu Fan 69,303$137,9129.78%
Decheng Capital Management III (Cayman), LLC 326,810$650,3520.22%
Harvest Investment Services, LLC 113,894$226,6490.15%
Laurion Capital Management LP 3,170,803$6,309,8980.04%
CORNERCAP INVESTMENT COUNSEL INC 74,903$149,0570.03%
SCHULHOFF & CO INC 22,000$43,7800.02%
HHLR ADVISORS, LTD. 382,606$761,3860.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 236,195$470,0280.01%
ExodusPoint Capital Management, LP 415,072$8260.01%
Bleakley Financial Group, LLC 11,234$22,3560.00%
View complete list of PYXIS ONCOLOGY INC shareholders